DE69526934D1 - Medikamente zur behandlung von restenosis, enthaltend stickstoff freisetzende polymere - Google Patents
Medikamente zur behandlung von restenosis, enthaltend stickstoff freisetzende polymereInfo
- Publication number
- DE69526934D1 DE69526934D1 DE69526934T DE69526934T DE69526934D1 DE 69526934 D1 DE69526934 D1 DE 69526934D1 DE 69526934 T DE69526934 T DE 69526934T DE 69526934 T DE69526934 T DE 69526934T DE 69526934 D1 DE69526934 D1 DE 69526934D1
- Authority
- DE
- Germany
- Prior art keywords
- nitric oxide
- releasing
- delivery means
- medicines
- restenosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F8/00—Chemical modification by after-treatment
- C08F8/30—Introducing nitrogen atoms or nitrogen-containing groups
- C08F8/32—Introducing nitrogen atoms or nitrogen-containing groups by reaction with amines
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Polymers & Plastics (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- General Preparation And Processing Of Foods (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Polyethers (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/214,372 US5650447A (en) | 1992-08-24 | 1994-03-17 | Nitric oxide-releasing polymers to treat restenosis and related disorders |
PCT/US1995/003040 WO1995024908A1 (en) | 1994-03-17 | 1995-03-09 | Use of nitric oxide-releasing polymers to treat restenosis and related disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69526934D1 true DE69526934D1 (de) | 2002-07-11 |
DE69526934T2 DE69526934T2 (de) | 2003-01-02 |
Family
ID=22798839
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69526934T Expired - Fee Related DE69526934T2 (de) | 1994-03-17 | 1995-03-09 | Medikamente zur behandlung von restenosis, enthaltend stickstoff freisetzende polymere |
Country Status (11)
Country | Link |
---|---|
US (1) | US5650447A (de) |
EP (1) | EP0752866B1 (de) |
JP (1) | JPH10502905A (de) |
AT (1) | ATE218352T1 (de) |
AU (1) | AU698525B2 (de) |
CA (1) | CA2185457C (de) |
DE (1) | DE69526934T2 (de) |
DK (1) | DK0752866T3 (de) |
ES (1) | ES2177637T3 (de) |
PT (1) | PT752866E (de) |
WO (1) | WO1995024908A1 (de) |
Families Citing this family (132)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5811447A (en) * | 1993-01-28 | 1998-09-22 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US6515009B1 (en) | 1991-09-27 | 2003-02-04 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5632981A (en) * | 1992-08-24 | 1997-05-27 | The United States Of America As Represented By The Department Of Health And Human Services | Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same |
US6255277B1 (en) | 1993-09-17 | 2001-07-03 | Brigham And Women's Hospital | Localized use of nitric oxide-adducts to prevent internal tissue damage |
US5681278A (en) * | 1994-06-23 | 1997-10-28 | Cormedics Corp. | Coronary vasculature treatment method |
GB9423868D0 (en) * | 1994-11-25 | 1995-01-11 | Wellcome Found | Compounds for use in medicine |
ES2421306T3 (es) * | 1994-12-12 | 2013-08-30 | Omeros Corporation | Solución de irrigación y procedimiento para inhibir el dolor, la inflamación y los espasmos |
US6063407A (en) * | 1995-02-16 | 2000-05-16 | The General Hospital Corporation | Treatment of vascular thrombosis and restenosis with inhaled nitric oxide |
US20050152950A1 (en) * | 1995-11-13 | 2005-07-14 | Saffran Bruce N. | Method and apparatus for macromolecular delivery using a coated membrane |
US6232434B1 (en) | 1996-08-02 | 2001-05-15 | Duke University Medical Center | Polymers for delivering nitric oxide in vivo |
US5770645A (en) * | 1996-08-02 | 1998-06-23 | Duke University Medical Center | Polymers for delivering nitric oxide in vivo |
EP0946160A4 (de) * | 1996-08-27 | 2007-05-09 | Univ Akron | Lipophile polyaminester zur ortsspezifischen abgabevon stickstoffmonoxid in pharmazeutischer anwendung |
US6372796B1 (en) * | 1996-11-13 | 2002-04-16 | Cold Spring Harbor Laboratory | Therapeutic uses for nitric oxide inhibitors |
US5994444A (en) * | 1997-10-16 | 1999-11-30 | Medtronic, Inc. | Polymeric material that releases nitric oxide |
US6221425B1 (en) | 1998-01-30 | 2001-04-24 | Advanced Cardiovascular Systems, Inc. | Lubricious hydrophilic coating for an intracorporeal medical device |
US20040254635A1 (en) | 1998-03-30 | 2004-12-16 | Shanley John F. | Expandable medical device for delivery of beneficial agent |
US7208010B2 (en) | 2000-10-16 | 2007-04-24 | Conor Medsystems, Inc. | Expandable medical device for delivery of beneficial agent |
US6241762B1 (en) | 1998-03-30 | 2001-06-05 | Conor Medsystems, Inc. | Expandable medical device with ductile hinges |
US5962520A (en) * | 1998-04-02 | 1999-10-05 | The University Of Akron | Hydrolytically unstable, biocompatible polymer |
US6207855B1 (en) | 1998-06-23 | 2001-03-27 | Duke University Medical Center | Stable no-delivering compounds |
US20040043068A1 (en) * | 1998-09-29 | 2004-03-04 | Eugene Tedeschi | Uses for medical devices having a lubricious, nitric oxide-releasing coating |
US6645167B1 (en) * | 1999-05-21 | 2003-11-11 | Micro Therapeutics, Inc. | Methods for embolizing vascular sites with an embolizing composition |
US7018365B2 (en) | 1999-05-21 | 2006-03-28 | Micro Therapeutics, Inc. | Threaded syringe with quick stop |
JP2003500106A (ja) * | 1999-05-21 | 2003-01-07 | マイクロ・セラピューティクス・インコーポレーテッド | 一様分散させた高粘度塞栓性組成物を生体内で搬送するための方法 |
WO2001010344A1 (en) * | 1999-08-04 | 2001-02-15 | C.R. Bard, Inc. | Nitric oxide releasing medical devices |
US7526342B2 (en) * | 1999-08-10 | 2009-04-28 | Maquet Cardiovascular Llc | Apparatus for endoscopic cardiac mapping and lead placement |
US20030187461A1 (en) * | 1999-08-10 | 2003-10-02 | Chin Albert K. | Releasable guide and method for endoscopic cardiac lead placement |
US7288096B2 (en) | 2003-01-17 | 2007-10-30 | Origin Medsystems, Inc. | Apparatus for placement of cardiac defibrillator and pacer |
US7398781B1 (en) * | 1999-08-10 | 2008-07-15 | Maquet Cardiovascular, Llc | Method for subxiphoid endoscopic access |
US7597698B2 (en) * | 1999-08-10 | 2009-10-06 | Maquet Cardiovascular Llc | Apparatus and method for endoscopic encirclement of pulmonary veins for epicardial ablation |
US20040102804A1 (en) * | 1999-08-10 | 2004-05-27 | Chin Albert K. | Apparatus and methods for endoscopic surgical procedures |
US6569082B1 (en) | 1999-08-10 | 2003-05-27 | Origin Medsystems, Inc. | Apparatus and methods for cardiac restraint |
US20060287574A1 (en) * | 1999-08-25 | 2006-12-21 | Chin Albert K | Longitudinal dilator |
US6660260B1 (en) * | 1999-09-21 | 2003-12-09 | Mayo Foundation For Medical Education And Research | Bioprosthetic heart valves |
EP1250166B1 (de) | 2000-01-25 | 2010-03-17 | Edwards Lifesciences Corporation | Freisetzungssysteme zur behandlung von restenose und anastomotischer intimaler hyperplasie |
US6270779B1 (en) * | 2000-05-10 | 2001-08-07 | United States Of America | Nitric oxide-releasing metallic medical devices |
ATE412475T1 (de) | 2000-08-11 | 2008-11-15 | David R Whitlock | Ammoniak-oxidierende bakterien enthaltende zusammensetzungen zur steigerung der stickoxidproduktion, stickoxid-vorläufer und verfahren zu deren verwendung |
US6797743B2 (en) * | 2000-09-27 | 2004-09-28 | Michigan Biotechnology Institute | Antimicrobial polymer |
US20050043506A1 (en) * | 2000-09-27 | 2005-02-24 | Michigan Biotechnology Institute | Polyamide materials based on unsaturated carboxylic acids and amines |
WO2002030487A2 (en) * | 2000-10-11 | 2002-04-18 | Micro Thereapeutics, Inc. | Methods for treating aneurysms |
DE60142131D1 (de) | 2000-10-16 | 2010-06-24 | Conor Medsystems Inc | Expandierbare medizinische Vorrichtung zur Freisetzung eines Heilmittels |
US7049308B2 (en) * | 2000-10-26 | 2006-05-23 | Duke University | C-nitroso compounds and use thereof |
US6565601B2 (en) | 2000-11-15 | 2003-05-20 | Micro Therapeutics, Inc. | Methods for vascular reconstruction of diseased arteries |
WO2002051383A2 (en) * | 2000-12-27 | 2002-07-04 | Genzyme Corporation | Controlled release of anti-arrhythmic agents from a biodegradable polyethylene oxide hydrogel for local application to the heart |
US20040073294A1 (en) | 2002-09-20 | 2004-04-15 | Conor Medsystems, Inc. | Method and apparatus for loading a beneficial agent into an expandable medical device |
WO2002087508A2 (en) | 2001-05-02 | 2002-11-07 | Nitromed, Inc. | Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use |
EP1436018A1 (de) * | 2001-09-26 | 2004-07-14 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Stickoxid freisetzende beschichtete medizinprodukte und verfahren zu ihrer herstellung |
US6703046B2 (en) * | 2001-10-04 | 2004-03-09 | Medtronic Ave Inc. | Highly cross-linked, extremely hydrophobic nitric oxide-releasing polymers and methods for their manufacture and use |
CA2473097A1 (en) * | 2002-01-11 | 2003-07-17 | David R. Whitlock | Compositions including ammonia oxidizing bacteria and methods of using same |
US6939554B2 (en) * | 2002-02-05 | 2005-09-06 | Michigan Biotechnology Institute | Antimicrobial polymer |
TW200307734A (en) | 2002-03-20 | 2003-12-16 | Michigan Biotech Inst | Conductive polymer-based material |
EP1490045B1 (de) * | 2002-03-21 | 2013-03-13 | University of Utah Research Foundation | In vivo Verwendung von durch Glutathionon s-Transferase aktivierten Stickoxid-Donatoren |
WO2003095398A2 (en) * | 2002-05-07 | 2003-11-20 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same |
AU2003229016A1 (en) * | 2002-05-10 | 2003-11-11 | The Trustees Of Columbia University In The City Of New York | Genetically engineered cell lines and systems for propagatingvaricella zoster virus and methods of use thereof |
WO2004012874A1 (en) | 2002-08-02 | 2004-02-12 | The Government Of The United States Of America, Represented By The Secretary, Dept. Of Health And Human Services | Cross-linked nitric oxide-releasing polyamine coated substrates, compositions comprising same and method of making same |
US6951902B2 (en) * | 2002-08-16 | 2005-10-04 | Michigan Biotechnology Institute | Two dimensional polymer that generates nitric oxide |
WO2004087214A1 (en) | 2003-03-28 | 2004-10-14 | Conor Medsystems, Inc. | Implantable medical device with beneficial agent concentration gradient |
DK1624953T3 (en) * | 2003-04-23 | 2019-04-01 | Univ Akron | Sequestered reactive materials |
AU2004253749B2 (en) | 2003-07-03 | 2010-04-01 | The University Court Of The University Of St Andrews | Zeolites for delivery of nitric oxide |
WO2005018561A2 (en) * | 2003-08-20 | 2005-03-03 | Nitromed, Inc. | Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use |
EP1667643A4 (de) * | 2003-08-28 | 2008-03-05 | Nitromed Inc | Nitrosierte und nitrosylierte kardiovaskuläre verbindungen, zusammensetzungen und anwendungsverfahren |
US7785653B2 (en) | 2003-09-22 | 2010-08-31 | Innovational Holdings Llc | Method and apparatus for loading a beneficial agent into an expandable medical device |
US7379190B2 (en) * | 2004-01-05 | 2008-05-27 | Zygo Corporation | Stage alignment in lithography tools |
AU2005207037A1 (en) * | 2004-01-22 | 2005-08-04 | Nitromed, Inc. | Nitrosated and/or nitrosylated compounds, compositions and methods of use |
EP1737502B1 (de) * | 2004-01-22 | 2014-01-15 | The University of Akron | Polymer-no-donor-prädrug-nanofaser-beschichtung für medizinprodukte |
US20050165452A1 (en) * | 2004-01-28 | 2005-07-28 | Medtronic, Inc. | Antithrombogenic medical device |
AU2005215969B2 (en) * | 2004-02-09 | 2009-07-30 | Amulet Pharmaceuticals, Inc. | Nitric oxide-releasing polymers |
US20070191377A1 (en) * | 2004-03-31 | 2007-08-16 | Nitromed, Inc. | Methods for treating blood disorders with nitric oxide donor compounds |
US20060039950A1 (en) * | 2004-08-23 | 2006-02-23 | Zhengrong Zhou | Multi-functional biocompatible coatings for intravascular devices |
CA2581939C (en) * | 2004-09-27 | 2013-01-08 | Joseph A. Hrabie | Nitric oxide-releasing diazeniumdiolated acrylonitrile-based polymers, and compositions, medical devices, and uses thereof |
WO2006041855A2 (en) | 2004-10-04 | 2006-04-20 | Nitromed, Inc. | Compositions and methods using apocynin compounds and nitric oxide donors |
EP1814535A4 (de) * | 2004-11-08 | 2008-06-04 | Nitromed Inc | Nitrosierte und nitrosylierte verbindungen, zusammensetzungen und verfahren zur behandlung von augenkrankheiten |
US9050393B2 (en) | 2005-02-08 | 2015-06-09 | Bruce N. Saffran | Medical devices and methods for modulation of physiology using device-based surface chemistry |
WO2006084914A2 (en) * | 2005-02-11 | 2006-08-17 | Nolabs Ab | Device for gastric treatment and manufacturing process for the same |
EP1690532A1 (de) * | 2005-02-11 | 2006-08-16 | NOLabs AB | Vorrichtung zur Behandlung vom Magen und ihr Verfahren zur Herstellung |
DK1846058T3 (da) * | 2005-02-11 | 2009-11-23 | Nolabs Ab | Indretning, fremgangsmåde og anvendelse til behandling af neuropati med nitrogenoxid |
EP1858863A1 (de) * | 2005-02-28 | 2007-11-28 | Nitromed, Inc. | Stickstoffmonoxid-verstärkende gruppen enthaltende cardiovaskuläre verbindungen, zusammensetzungen und anwendungsverfahren |
AU2006223392A1 (en) * | 2005-03-09 | 2006-09-21 | Nicox S.A. | Organic nitric oxide enhancing salts of angiotensin II antagonists, compositions and methods of use |
JP2008535858A (ja) * | 2005-04-07 | 2008-09-04 | ニトロメッド インコーポレーティッド | 心不全における遺伝リスク、すなわちnos3の遺伝子変異の影響の評価方法 |
EP1883614A4 (de) * | 2005-05-23 | 2010-04-14 | Nicox Sa | Organische stickoxide verbessernde salze aus nichtsteroiden entzündungshemmenden verbindungen sowie zusammensetzungen und verwendungsverfahren dafür |
CA2606565C (en) | 2005-05-27 | 2016-05-10 | The University Of North Carolina At Chapel Hill | Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications |
WO2007005758A2 (en) * | 2005-06-30 | 2007-01-11 | Mc3, Inc. | Methods , compositions and devices for promoting angiogenesis |
US20090118819A1 (en) * | 2005-06-30 | 2009-05-07 | Mc3, Inc. | Nitric Oxide Coatings for Medical Devices |
CA2613106A1 (en) * | 2005-06-30 | 2007-01-11 | Mc3, Inc. | Analyte sensors and compositions for use therein |
WO2007016677A2 (en) | 2005-08-02 | 2007-02-08 | Nitromed, Inc. | Nitric oxide enhancing antimicrobial compounds, compositions and methods of use |
US8021679B2 (en) | 2005-08-25 | 2011-09-20 | Medtronic Vascular, Inc | Nitric oxide-releasing biodegradable polymers useful as medical devices and coatings therefore |
US20070053952A1 (en) * | 2005-09-07 | 2007-03-08 | Medtronic Vascular, Inc. | Nitric oxide-releasing polymers derived from modified polymers |
US20090192128A1 (en) * | 2005-10-04 | 2009-07-30 | Nitromed Inc. | Genetic risk assessment in heart failure: impact of genetic variation of beta 1 adrenergic receptor gly389arg polymorphism |
EP1942942A2 (de) * | 2005-10-31 | 2008-07-16 | Government of the United States of America, Represented by the Secretary, Department of Health and Human Services | Von polysaccharid stammende stickoxid-freisetzende kohlenstoffgebundene diazeniumdiolate |
EP1954685A4 (de) * | 2005-11-16 | 2009-11-11 | Nitromed Inc | Furoxanverbindungen, zusammensetzungen und anwendungsverfahren |
EP1968664B1 (de) * | 2005-12-02 | 2010-10-27 | The Regents Of The University Of Michigan | Polymerzusammensetzungen, überzüge und vorrichtungen und herstellungs- und anwendungsverfahren damit |
AU2006322035A1 (en) * | 2005-12-06 | 2007-06-14 | Amulet Pharmaceuticals, Inc. | Nitric oxide-releasing polymers |
WO2007075541A2 (en) * | 2005-12-20 | 2007-07-05 | Nitromed, Inc. | Nitric oxide enhancing glutamic acid compounds, compositions and methods of use |
AU2007243765A1 (en) | 2006-03-29 | 2007-11-08 | Nicox S.A. | Nitric oxide enhancing prostaglandin compounds, compositions and methods of use |
US8241619B2 (en) * | 2006-05-15 | 2012-08-14 | Medtronic Vascular, Inc. | Hindered amine nitric oxide donating polymers for coating medical devices |
US7811600B2 (en) * | 2007-03-08 | 2010-10-12 | Medtronic Vascular, Inc. | Nitric oxide donating medical devices and methods of making same |
US8273828B2 (en) | 2007-07-24 | 2012-09-25 | Medtronic Vascular, Inc. | Methods for introducing reactive secondary amines pendant to polymers backbones that are useful for diazeniumdiolation |
WO2009059271A1 (en) * | 2007-11-02 | 2009-05-07 | University Of Miami | Diagnosis and treatment of cardiac disorders |
WO2009064861A2 (en) * | 2007-11-13 | 2009-05-22 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Nitric oxide-releasing diazeniumdiolated polymers, compositions, medical devices, and uses thereof |
US20090170933A1 (en) * | 2007-12-26 | 2009-07-02 | Cook Incorporated | Method for removing a medical device from a spasmodic constriction in a bodily passageway |
US12035964B2 (en) | 2007-12-27 | 2024-07-16 | Boston Scientific Medical Device Limited | Electrosurgical pericardial puncture |
US20090222088A1 (en) * | 2008-02-29 | 2009-09-03 | Medtronic Vascular, Inc. | Secondary Amine Containing Nitric Oxide Releasing Polymer Composition |
CA2717867C (en) | 2008-03-07 | 2017-05-30 | Paul J. Shami | Activated nitric oxide donors and methods of making and using thereof |
US20090232863A1 (en) * | 2008-03-17 | 2009-09-17 | Medtronic Vascular, Inc. | Biodegradable Carbon Diazeniumdiolate Based Nitric Oxide Donating Polymers |
US20090232868A1 (en) * | 2008-03-17 | 2009-09-17 | Medtronic Vascular, Inc. | Nitric Oxide Releasing Polymer Composition |
EP2260060A4 (de) | 2008-04-01 | 2013-01-16 | Univ Cornell | Organisch lösliche chitosansalze und daraus hergestellte chitosan-abgeleitete biomaterialien |
US8158187B2 (en) * | 2008-12-19 | 2012-04-17 | Medtronic Vascular, Inc. | Dry diazeniumdiolation methods for producing nitric oxide releasing medical devices |
US8709465B2 (en) | 2009-04-13 | 2014-04-29 | Medtronic Vascular, Inc. | Diazeniumdiolated phosphorylcholine polymers for nitric oxide release |
US9265633B2 (en) | 2009-05-20 | 2016-02-23 | 480 Biomedical, Inc. | Drug-eluting medical implants |
JP5820370B2 (ja) * | 2009-05-20 | 2015-11-24 | アーセナル メディカル, インコーポレイテッド | 医療用移植片 |
US8888840B2 (en) * | 2009-05-20 | 2014-11-18 | Boston Scientific Scimed, Inc. | Drug eluting medical implant |
US9309347B2 (en) | 2009-05-20 | 2016-04-12 | Biomedical, Inc. | Bioresorbable thermoset polyester/urethane elastomers |
US8992601B2 (en) | 2009-05-20 | 2015-03-31 | 480 Biomedical, Inc. | Medical implants |
US20110319987A1 (en) | 2009-05-20 | 2011-12-29 | Arsenal Medical | Medical implant |
SI2440239T1 (en) | 2009-06-09 | 2018-01-31 | Prolong Pharmaceuticals, LLC | Hemoglobin compositions |
US9526738B2 (en) | 2009-08-21 | 2016-12-27 | Novan, Inc. | Topical gels and methods of using the same |
DK2467173T3 (da) | 2009-08-21 | 2019-07-29 | Novan Inc | Sårbandager, fremgangsmåder til anvendelse heraf og fremgangsmåder til dannelse deraf |
US8372133B2 (en) * | 2009-10-05 | 2013-02-12 | 480 Biomedical, Inc. | Polymeric implant delivery system |
US20110301299A1 (en) | 2010-06-08 | 2011-12-08 | Medtronic Vascular, Inc. | Medical Devices and Polymers Therefor Having PTFE Surfaces Modified With Nitric Oxide-Releasing Polymers |
US8591876B2 (en) | 2010-12-15 | 2013-11-26 | Novan, Inc. | Methods of decreasing sebum production in the skin |
EP2681286B1 (de) | 2011-02-28 | 2018-08-15 | Novan, Inc. | Stickoxid-freisetzende s-nitrosothiol-modifizierte kieselsäureteilchen und verfahren zu ihrer herstellung |
EP2707103A2 (de) | 2011-05-09 | 2014-03-19 | Topical Therapeutic Agent (TTA) Ltd. | Stickoxidsequestrierung von topischen formulierungen |
US11225640B2 (en) | 2014-04-15 | 2022-01-18 | Aobiome Llc | Ammonia oxidizing bacteria for treatment of psoriasis |
KR20210100224A (ko) | 2014-04-15 | 2021-08-13 | 에이오바이오미 엘엘씨 | 암모니아-산화 니트로소모나스 유트로파 균주 d23 |
EP3180366B1 (de) * | 2014-08-14 | 2018-09-26 | Rohm and Haas Company | Polymer mit freisetzbarem gas |
EP3253485B1 (de) | 2015-02-03 | 2021-12-15 | University Court of The University of St Andrews | No-haltige zusammensetzungen |
US11186681B2 (en) | 2016-10-07 | 2021-11-30 | The University Of North Carolina At Chapel Hill | S-Nitrosothiol-mediated hyperbranched polyesters |
CA3048785A1 (en) | 2017-01-03 | 2018-07-12 | The University Of North Carolina At Chapel Hill | Nitric oxide-releasing alginates as biodegradable antibacterial scaffolds and methods pertaining thereto |
US11723914B2 (en) | 2017-03-28 | 2023-08-15 | The University Of North Carolina At Chapel Hill | Nitric oxide-releasing polyaminoglycosides as biodegradable antibacterial scaffolds and methods pertaining thereto |
CA3091458A1 (en) | 2018-03-06 | 2019-09-12 | The University Of North Carolina At Chapel Hill | Nitric oxide-releasing cyclodextrins as biodegradable antibacterial scaffolds and methods pertaining thereto |
EP3902841A4 (de) | 2018-12-28 | 2022-09-28 | The University of North Carolina at Chapel Hill | Stickoxidfreisetzende antibakterielle polymere und daraus hergestellte gerüste und verfahren dazu |
US20230140515A1 (en) * | 2021-11-03 | 2023-05-04 | Baxter International Inc. | Nitric oxide donors for use in surgical recovery |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL151996B (nl) * | 1971-04-15 | 1977-01-17 | Snam Progetti | Werkwijze voor de bereiding van gemodificeerde polymeren. |
US4954526A (en) * | 1989-02-28 | 1990-09-04 | The United States Of America As Represented By The Department Of Health And Human Services | Stabilized nitric oxide - primary amine complexes useful as cardiovascular agents |
US5208233A (en) * | 1989-09-15 | 1993-05-04 | The United States Of America As Represented By The Department Of Health And Human Services | Anti-hypertensive compositions of secondary amine-nitric oxide adducts and use thereof |
US5039705A (en) * | 1989-09-15 | 1991-08-13 | The United States Of America As Represented By The Department Of Health And Human Services | Anti-hypertensive compositions of secondary amine-nitric oxide adducts and use thereof |
US5212204A (en) * | 1989-10-18 | 1993-05-18 | The United States Of America As Represented By The Department Of Health And Human Services | Antihypertensive compositions and use thereof |
US5155137A (en) * | 1990-09-20 | 1992-10-13 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Complexes of nitric oxide with polyamines |
US5185376A (en) * | 1991-09-24 | 1993-02-09 | The United States Of America As Represented By The Department Of Health And Human Services | Therapeutic inhibition of platelet aggregation by nucleophile-nitric oxide complexes and derivatives thereof |
US5219710A (en) * | 1991-11-25 | 1993-06-15 | Allied-Signal Inc. | Polymeric nitrones having a styrene-derived backbone chain |
-
1994
- 1994-03-17 US US08/214,372 patent/US5650447A/en not_active Expired - Fee Related
-
1995
- 1995-03-09 AT AT95912871T patent/ATE218352T1/de not_active IP Right Cessation
- 1995-03-09 WO PCT/US1995/003040 patent/WO1995024908A1/en active IP Right Grant
- 1995-03-09 CA CA002185457A patent/CA2185457C/en not_active Expired - Fee Related
- 1995-03-09 EP EP95912871A patent/EP0752866B1/de not_active Expired - Lifetime
- 1995-03-09 DE DE69526934T patent/DE69526934T2/de not_active Expired - Fee Related
- 1995-03-09 DK DK95912871T patent/DK0752866T3/da active
- 1995-03-09 JP JP7524103A patent/JPH10502905A/ja active Pending
- 1995-03-09 ES ES95912871T patent/ES2177637T3/es not_active Expired - Lifetime
- 1995-03-09 PT PT95912871T patent/PT752866E/pt unknown
- 1995-03-09 AU AU19889/95A patent/AU698525B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
CA2185457A1 (en) | 1995-09-21 |
CA2185457C (en) | 2004-05-25 |
US5650447A (en) | 1997-07-22 |
PT752866E (pt) | 2002-11-29 |
DK0752866T3 (da) | 2002-09-16 |
ATE218352T1 (de) | 2002-06-15 |
JPH10502905A (ja) | 1998-03-17 |
WO1995024908A1 (en) | 1995-09-21 |
ES2177637T3 (es) | 2002-12-16 |
EP0752866B1 (de) | 2002-06-05 |
EP0752866A1 (de) | 1997-01-15 |
AU1988995A (en) | 1995-10-03 |
DE69526934T2 (de) | 2003-01-02 |
AU698525B2 (en) | 1998-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69526934D1 (de) | Medikamente zur behandlung von restenosis, enthaltend stickstoff freisetzende polymere | |
ATE209908T1 (de) | RADIKALFÄNGER (ßSPIN TRAPSß) ZUR BEHANDLUNG VON MIT OXIDATION VON LIPIDEN UND PROTEINEN VERBUNDENEN ERKRANKUNGEN | |
BR9814389A (pt) | Forma de dosagem farmacêutica revestida entérica, processo para a preparação da mesma, uso desta, pelota ou tablete encamado para a mesma, e, processos para melhorar a inibição da secreção de ácido gástrico, e para melhorar o efeito terapêutico no tratamento de distúrbios gastrointestinais associados com secreção de ácido em excesso | |
ATE184792T1 (de) | 2-bromomelatonin zur behandlung von schlafstörungen | |
NZ504026A (en) | Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C | |
DE60321929D1 (de) | Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen | |
GEP20043297B (en) | Bicyclic Amino Acids as Pharmaceutical Agents | |
ATE311867T1 (de) | Analgetische zusammensetzung enthaltend antiepileptische arzneistoffe und deren verwendungen | |
DE69805202D1 (de) | Verwendung von benzhydrylsulfinylderivaten zur behandlung der schläfigkeit medikamentösen ursprungs | |
ATE101515T1 (de) | Verwendung einer zusammensetzung zur herstellung eines arzneimittels zur behandlung der symptome der unenthaltsamkeit. | |
GEP20043216B (en) | Orally Administered Controlled Drug Delivery System | |
DE69906671D1 (de) | Substituierte 2-Phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanone, deren Verwendung zur Behandlung von Erkrankungen des zentralen und periphären Nervensystems und diese enthaltende pharmazeutische Zusammensetzungen | |
ATE198706T1 (de) | Polyamin-verbindungen zur behandlung von proliferativer erkrankungen | |
ATE171869T1 (de) | Film zur lokalen arzneistoffabgabe für periodontale behandlung | |
DE69826023D1 (de) | Verwendung von substanzen mit oxytocinwirkung zur herstellung eines arzneimittels zur behandlung affektiver schmerzsyndrome | |
DE69424777D1 (de) | 3,4-diarylchromane zur behandlung von dermatitis | |
BR9500436A (pt) | Produtos uso de um g-csf uso de uma proteína tnf ligante processo para o tratamento e/ou prevenção do choque séptico | |
CA2156481A1 (en) | 5-ht2 receptor antagonist compositions useful in treating venous conditions | |
ATE232390T1 (de) | Osmotisches nicht-fermentiertes laxans zur behandlung und vorbeugung von kolorektalem krebs | |
DE69633396D1 (de) | Activin stimulator enthaltende pharmazeutische zusammensetzung | |
RU2001124802A (ru) | Применение саредутанта и его фармацевтически приемлемых солей для приготовления лекарственных средств, применяемых для лечения или предупреждения расстройств настроения, расстройств адаптации или смешанных тревожно-депрессивных расстройств | |
RU94040886A (ru) | Применение производных мелатонина для лечения нарушений сна, фармацевтическая композиция | |
RU94041028A (ru) | Применение производных мелатонина для лечения десинхронизационных нарушений, фармацевтическая композиция | |
ATE255411T1 (de) | Hyaluronsäurerezeptoren bindende stoffe und deren verwendung zur behandlung von tumoren und restenose | |
DE69623316D1 (de) | Ctla-8 in kombination mit g-csf oder mit g-csf und il-6, und verwendung vom ctla-8 zur behandlung von infektionen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |